Non-alcoholic fatty liver disease and cardiovascular pathology: features of patient management on a clinical example-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease and cardiovascular pathology: features of patient management on a clinical example

Published:2022-10-07 Issue:9 Volume: Page:290-297
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Pakhomova I. G.¹^ORCID,Knorring G. Yu.²^ORCID

Affiliation:

1. Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation

2. Moscow State University of Medicine and Dentistry named after A. I. Evdakimov

Abstract

Non-alcoholic fatty liver disease (NAFLD) is recognized as an interdisciplinary problem at the intersection of therapy, gastroenterology and endocrinology. In recent years, there has been a significant increase in interest in NAFLD as an accomplice of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM2). The article discusses the mechanisms of NAFLD in the development and progression of cardiovascular diseases depending on risk factors and comorbidity, including a clinical case. The proven clear association of NAFLD with obesity, DM 2, CVD suggests that these comorbid diseases are interdependent in their natural course. Pathogenetically substantiated management of NAFLD can positively influence the course of comorbid conditions. The role of ursodeoxycholic acid drugs in the treatment of NAFLD and the effect of this therapy on the course of associated diseases and conditions are discussed.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference49 articles.

1. Lang GF. Hypertonic disease. Leningrad: Medgiz; 1950. (In Russ.) @@Lang G. F. Gipertonicheskaya bolezn'. - L.: Medgiz; 1950.

2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. doi: 10.2337/diab.37.12.1595

3. Bloomgarden Z. T. Symposium: Debating the Metabolic Syndrome. Medscape Conference Coverage, based on selected sessions. American Diabetes Association 66th Scientific Sessions; June 9-13, 2006, Washington, DC.

4. Byrne C.D., Targher G. NAFLD: a multisystem disease. J. Hepatol. 2015 Apr;62(1 Suppl): S47-64. doi: 10.1016/j.jhep.2014.12.012.

5. Diagnosis and treatment of non-alcoholic fatty liver disease/ ed. V. T. Ivashkin. Methodical recommendations for doctors.Russian Society for the Study of the Liver. Moscow., 2015. 29 p. (in Russ.) @@Diagnostika i lechenie nealkogol'noi zhirovoi bolezni pecheni / pod red. akad. RAN, prof. V. T. Ivashkina. Metodicheskie rekomendatsii dlya vrachei. Rossiiskoe obshchestvo po izucheniyu pecheni. M., 2015. 29 s.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The phenomenon of metabolically associated fatty liver disease in the pathogenesis of cholelithiasis and hypertension;Experimental and Clinical Gastroenterology;2024-01-18